Press Releases

Varian to Equip New Ethos Personalized Adaptive Therapy Center in Phoenix

Varian (NYSE: VAR) today announced it was selected to equip the new Ethos Personalized Adaptive Therapy Center in Phoenix, Arizona, and help launch a new era in cancer treatment for patients in...

Varian Halcyon 2.0 Treatment System Receives China NMPA Approval

Varian (NYSE: VAR) today announced its Halcyon™ 2.0 treatment system has been approved by the China National Medical Products Administration (NMPA), which allows the company to market this...

Quebec Selects Varian to Increase Access to Advanced Cancer Care

Varian (NYSE: VAR) today announced that the procurement representative of the Quebec government, Groupe d'Approvisionnement Commun de l'Est du Québec (GACEQ), filed a notice of intent to award a...

Ethos Therapy Continues Global Expansion

Varian (NYSE: VAR) today announced Medisch Spectrum Twente Hospital in The Netherlands, and Icon Cancer Centre Wahroonga and Royal North Shore Hospital (RNSH) in Australia treated their first...

Varian Provides an Update on Expected Impact From COVID-19

Varian (NYSE: VAR) today announced that the COVID-19 outbreak will negatively impact the company's operating results. Across the company's Asia-Pacific geographies, healthcare resources are being...

Varian to Attend Upcoming Investor Events

Varian (NYSE: VAR) today announced that J. Michael Bruff, chief financial officer and Anshul Maheshwari, vice president, investor relations and treasurer will be participating in the following...

Varian Receives FDA 510(k) Clearance for Ethos Therapy

Varian (NYSE: VAR) today announced it has received FDA 510(k) clearance for its Ethos™ therapy, an Adaptive Intelligence™ solution. Ethos therapy is an artificial intelligence (AI)-driven...

Massachusetts General Hospital Selects Varian Radiotherapy Systems for Cancer Center

Varian (NYSE: VAR) today announced it has signed an agreement with Massachusetts General Hospital to provide seven Varian radiotherapy systems and related services for advanced cancer treatment at...

Varian Reports Results for First Quarter of Fiscal Year 2020

First Quarter 2020 Summary Oncology Systems gross orders grew 8% in dollars or 9% in constant currency in the quarter and over the trailing twelve months Total company revenues grew 12% in...

Varian Appoints Prof. Dr. Ricky Sharma VP of Clinical Affairs

Varian (NYSE: VAR) today announced it has appointed Dr. Ricky Sharma, to vice president of Clinical Affairs. In this role he will be leading medical research, translational science and clinical...